<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>新药汇 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-24T16:27:02+08:00</updated>
  <subtitle>新药研发和临床试验交流和分享</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2020盘点：164个「1类新药」首次IND，正大天晴、东阳光药…</title>
    <updated>2020-12-24T15:21:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/D83muqWg2G7YOrQ9TVZe9A</id>
    <link href="https://mp.weixin.qq.com/s/D83muqWg2G7YOrQ9TVZe9A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞「氟唑帕利」新适应症报上市！复发性卵巢癌维持治疗</title>
    <updated>2020-12-24T15:21:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/yyBNOHYg5grNfm9kO8qinw</id>
    <link href="https://mp.weixin.qq.com/s/yyBNOHYg5grNfm9kO8qinw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>为了规范肾脏病临床实验室检查及质量控制，提高对肾脏疾病相关实验室检查意义的认识，陕西省中医医院肾病医院将于2021年1月10日召</title>
    <updated>2020-12-24T15:21:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/2vLWdqhGDWYlWsyCsfKEFQ</id>
    <link href="https://mp.weixin.qq.com/s/2vLWdqhGDWYlWsyCsfKEFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《控制近视进展药物临床研究技术指导原则》</title>
    <updated>2020-12-24T15:21:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/f3VG_oYgJuJ4lp6wlYr5-A</id>
    <link href="https://mp.weixin.qq.com/s/f3VG_oYgJuJ4lp6wlYr5-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚！CDE发布《化学仿制药参比制剂目录（第三十六批）》的公示，累计86个参比未通过审议</title>
    <updated>2020-12-21T16:33:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/Ggxcix0r-rAWk-DPFFODPA</id>
    <link href="https://mp.weixin.qq.com/s/Ggxcix0r-rAWk-DPFFODPA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>临床试验方案沟通交流常见的统计学设计问题</title>
    <updated>2020-12-15T18:52:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/mBJG-24E1Nt8_4Ts5arsKw</id>
    <link href="https://mp.weixin.qq.com/s/mBJG-24E1Nt8_4Ts5arsKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>两款重磅1类新药获批：来自恒瑞、海思科</title>
    <updated>2020-12-15T18:52:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/8YDlDXud-nGhwaHQTX4rww</id>
    <link href="https://mp.weixin.qq.com/s/8YDlDXud-nGhwaHQTX4rww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020第四届BIFT中国生物制药创新与前沿技术峰会在上海浦东成功举办</title>
    <updated>2020-12-15T18:52:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/9E2uVXoXvF11FtwnxUMbkg</id>
    <link href="https://mp.weixin.qq.com/s/9E2uVXoXvF11FtwnxUMbkg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《药物研发与技术审评沟通交流管理办法》的通告</title>
    <updated>2020-12-11T15:42:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/-YRHoce_og6QBkRpLt_Luw</id>
    <link href="https://mp.weixin.qq.com/s/-YRHoce_og6QBkRpLt_Luw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NMPA：40个批文不予再注册！共115个药品注册证书注销！</title>
    <updated>2020-12-10T13:52:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/oRyPYmW53cLxG3RPCQcLQg</id>
    <link href="https://mp.weixin.qq.com/s/oRyPYmW53cLxG3RPCQcLQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅：有效率86%！中国疫苗在国外获批上市</title>
    <updated>2020-12-10T13:52:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/A4t9fP8e-94ZXsDJ40N5pQ</id>
    <link href="https://mp.weixin.qq.com/s/A4t9fP8e-94ZXsDJ40N5pQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗肿瘤药物临床试验中心实验室使用专家共识2019版</title>
    <updated>2020-12-10T13:52:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/MKEDAEW7AZzHQAlHch3Otw</id>
    <link href="https://mp.weixin.qq.com/s/MKEDAEW7AZzHQAlHch3Otw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家药监局综合司公开征求《药物警戒质量管理规范（征求意见稿）》意见</title>
    <updated>2020-12-04T14:27:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/5TFiworJaonnsOnvT11qiQ</id>
    <link href="https://mp.weixin.qq.com/s/5TFiworJaonnsOnvT11qiQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《单臂试验支持上市的抗肿瘤药进入关键试验前和上市许可申请前临床方面沟通交流技术指导原则》</title>
    <updated>2020-12-04T14:27:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/oAyCGLHl_s8aTGSoK_7sdg</id>
    <link href="https://mp.weixin.qq.com/s/oAyCGLHl_s8aTGSoK_7sdg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球首个新冠疫苗获批，离我们还有多远</title>
    <updated>2020-12-04T14:27:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/BqT4nhoezAAMo5Haa3fnpw</id>
    <link href="https://mp.weixin.qq.com/s/BqT4nhoezAAMo5Haa3fnpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021EBC免费门票来袭！限量1000张</title>
    <updated>2020-12-04T14:27:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/xMoF5-HIIkeCRUQfrY3GYw</id>
    <link href="https://mp.weixin.qq.com/s/xMoF5-HIIkeCRUQfrY3GYw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>石药集团“first-in-class”抗体新药在中国获批临床</title>
    <updated>2020-12-04T14:27:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/cxROVOr-oCdntm0dUFV0Ag</id>
    <link href="https://mp.weixin.qq.com/s/cxROVOr-oCdntm0dUFV0Ag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家药监局发布《真实世界数据用于医疗器械临床评价技术指导原则（试行）》</title>
    <updated>2020-11-26T11:24:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/5gXTJNH9N6xWhbwVG4rcnw</id>
    <link href="https://mp.weixin.qq.com/s/5gXTJNH9N6xWhbwVG4rcnw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新指南《临床试验设计六大核心要素之一：人群》推荐适应性设计和富集设计</title>
    <updated>2020-11-25T16:09:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/T4jrZVrNoeV4H5NbFESXwA</id>
    <link href="https://mp.weixin.qq.com/s/T4jrZVrNoeV4H5NbFESXwA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国非公立医疗机构协会正式“加盟”！ 重磅助力2020南京国际生命健康大会暨博览会</title>
    <updated>2020-11-25T16:09:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/Y-esLahfLOoISGDT10B_yg</id>
    <link href="https://mp.weixin.qq.com/s/Y-esLahfLOoISGDT10B_yg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>